Vadim T Ivanov

Title: Vadim T Ivanov: Innovator in Immunomodulation

Introduction

Vadim T Ivanov, an accomplished inventor based in Moscow, RU, has made significant contributions to the field of immunology through his innovative approaches and patentable inventions. With a portfolio of 3 patents, Ivanov focuses on pharmaceutical compositions that target immunodeficient and immunodepressed states, showcasing his dedication to advancing therapeutic options in this critical area.

Latest Patents

Ivanov's latest patents include:

1. **Pharmaceutical lysine-containing polypeptide compositions and methods of use thereof** - This patent details pharmaceutical compositions designed for the therapy of immunodeficient, immunodepressed, or hyperactive immune states. It outlines methods for preventing and treating opportunistic infections through the administration of compositions that feature key peptides.

2. **Immunomodulating peptides and methods of use** - This invention introduces peptides formulated as R'-Glx-Glx-Lys-R', wherein Glx is either Glu or Gln. This patent specifically provides access to peptides such as Thr-Ala-Glu-Glu-Lys and Thr-Pro-Glu-Glu-Lys, emphasizing their usefulness for immunomodulation alongside appropriate pharmaceutical compositions.

Career Highlights

Throughout his career, Vadim T Ivanov has contributed to the advancement of biomedical research through his work with notable companies, including Cytran, Inc. and Cytran Incorporation. His expertise in the development of innovative healthcare solutions has established him as a key figure in the pharmaceutical industry, particularly in the area of immunomodulation.

Collaborations

In his professional journey, Ivanov has had the opportunity to collaborate with esteemed colleagues, including Lawrence R Green and Inessa I Mikhalyova. These partnerships have further enriched his research and development efforts, leading to innovative breakthroughs in his field.

Conclusion

Vadim T Ivanov stands out as a pioneering inventor whose work focuses on improving health outcomes for individuals with compromised immune systems. His patents reflect a commitment to enhancing therapeutic options in the medical field, affirming his status as a valuable contributor to immunological research and innovation.